Trends in provision of photodynamic therapy and clinician attitudes: a tracker survey of a new health technology

Robbie C Foy, Barny Foot, Jill Francis, Usha Chakravarthy, Richard P L Wormald

Research output: Contribution to journalArticle

4 Downloads (Pure)

Abstract

Background: There has been debate about the cost-effectiveness of photodynamic therapy (PDT), a treatment for neovascular age-related macular degeneration. We have been monitoring trends for the provision of PDT in the UK National Health Service. The fourth annual 'tracker' survey took place as definitive National Institute for Clinical Excellence ( NICE) guidance was issued. We assessed trends in PDT provision up to the point of release of the NICE guidance and identified likely sources of pressure on ophthalmologists to provide PDT.

Methods: National postal questionnaire survey of clinicians with potential responsibility for PDT provision. The survey explored reported local provision, beliefs about the effectiveness of PDT and what sources of opinion might influence attitudes towards providing PDT.

Results: The response rate was 73% (111/150). Almost half of the surveyed ophthalmology units routinely provided PDT, as part of a trend of steady growth in provision. The proportion of respondents who believed that further proof of effectiveness was required has also declined despite the absence of any new substantial evidence. Attitudes towards providing PDT were positive, on average, and were more strongly associated with perceived social pressure from local colleagues than from other sources. Local colleagues were seen as being most approving of PDT.

Conclusion: Those responsible for implementing the NICE guidance need to address ophthalmologists' beliefs about the evidence of effectiveness for PDT and draw upon supportive local individuals or networks to enhance the credibility of the guidance.

Original languageEnglish
Article number34
Number of pages5
JournalBMC Health Services Research
Volume5
DOIs
Publication statusPublished - 10 May 2005

Keywords

  • subfoveal choroidal neovascularization
  • macular degeneration
  • verteporfin

Cite this

Trends in provision of photodynamic therapy and clinician attitudes : a tracker survey of a new health technology. / Foy, Robbie C; Foot, Barny; Francis, Jill; Chakravarthy, Usha; Wormald, Richard P L.

In: BMC Health Services Research, Vol. 5, 34, 10.05.2005.

Research output: Contribution to journalArticle

Foy, Robbie C ; Foot, Barny ; Francis, Jill ; Chakravarthy, Usha ; Wormald, Richard P L. / Trends in provision of photodynamic therapy and clinician attitudes : a tracker survey of a new health technology. In: BMC Health Services Research. 2005 ; Vol. 5.
@article{74c3d93ea7844a63a1d5b84fb01811cd,
title = "Trends in provision of photodynamic therapy and clinician attitudes: a tracker survey of a new health technology",
abstract = "Background: There has been debate about the cost-effectiveness of photodynamic therapy (PDT), a treatment for neovascular age-related macular degeneration. We have been monitoring trends for the provision of PDT in the UK National Health Service. The fourth annual 'tracker' survey took place as definitive National Institute for Clinical Excellence ( NICE) guidance was issued. We assessed trends in PDT provision up to the point of release of the NICE guidance and identified likely sources of pressure on ophthalmologists to provide PDT.Methods: National postal questionnaire survey of clinicians with potential responsibility for PDT provision. The survey explored reported local provision, beliefs about the effectiveness of PDT and what sources of opinion might influence attitudes towards providing PDT.Results: The response rate was 73{\%} (111/150). Almost half of the surveyed ophthalmology units routinely provided PDT, as part of a trend of steady growth in provision. The proportion of respondents who believed that further proof of effectiveness was required has also declined despite the absence of any new substantial evidence. Attitudes towards providing PDT were positive, on average, and were more strongly associated with perceived social pressure from local colleagues than from other sources. Local colleagues were seen as being most approving of PDT.Conclusion: Those responsible for implementing the NICE guidance need to address ophthalmologists' beliefs about the evidence of effectiveness for PDT and draw upon supportive local individuals or networks to enhance the credibility of the guidance.",
keywords = "subfoveal choroidal neovascularization, macular degeneration, verteporfin",
author = "Foy, {Robbie C} and Barny Foot and Jill Francis and Usha Chakravarthy and Wormald, {Richard P L}",
year = "2005",
month = "5",
day = "10",
doi = "10.1186/1472-6963-5-34",
language = "English",
volume = "5",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Trends in provision of photodynamic therapy and clinician attitudes

T2 - a tracker survey of a new health technology

AU - Foy, Robbie C

AU - Foot, Barny

AU - Francis, Jill

AU - Chakravarthy, Usha

AU - Wormald, Richard P L

PY - 2005/5/10

Y1 - 2005/5/10

N2 - Background: There has been debate about the cost-effectiveness of photodynamic therapy (PDT), a treatment for neovascular age-related macular degeneration. We have been monitoring trends for the provision of PDT in the UK National Health Service. The fourth annual 'tracker' survey took place as definitive National Institute for Clinical Excellence ( NICE) guidance was issued. We assessed trends in PDT provision up to the point of release of the NICE guidance and identified likely sources of pressure on ophthalmologists to provide PDT.Methods: National postal questionnaire survey of clinicians with potential responsibility for PDT provision. The survey explored reported local provision, beliefs about the effectiveness of PDT and what sources of opinion might influence attitudes towards providing PDT.Results: The response rate was 73% (111/150). Almost half of the surveyed ophthalmology units routinely provided PDT, as part of a trend of steady growth in provision. The proportion of respondents who believed that further proof of effectiveness was required has also declined despite the absence of any new substantial evidence. Attitudes towards providing PDT were positive, on average, and were more strongly associated with perceived social pressure from local colleagues than from other sources. Local colleagues were seen as being most approving of PDT.Conclusion: Those responsible for implementing the NICE guidance need to address ophthalmologists' beliefs about the evidence of effectiveness for PDT and draw upon supportive local individuals or networks to enhance the credibility of the guidance.

AB - Background: There has been debate about the cost-effectiveness of photodynamic therapy (PDT), a treatment for neovascular age-related macular degeneration. We have been monitoring trends for the provision of PDT in the UK National Health Service. The fourth annual 'tracker' survey took place as definitive National Institute for Clinical Excellence ( NICE) guidance was issued. We assessed trends in PDT provision up to the point of release of the NICE guidance and identified likely sources of pressure on ophthalmologists to provide PDT.Methods: National postal questionnaire survey of clinicians with potential responsibility for PDT provision. The survey explored reported local provision, beliefs about the effectiveness of PDT and what sources of opinion might influence attitudes towards providing PDT.Results: The response rate was 73% (111/150). Almost half of the surveyed ophthalmology units routinely provided PDT, as part of a trend of steady growth in provision. The proportion of respondents who believed that further proof of effectiveness was required has also declined despite the absence of any new substantial evidence. Attitudes towards providing PDT were positive, on average, and were more strongly associated with perceived social pressure from local colleagues than from other sources. Local colleagues were seen as being most approving of PDT.Conclusion: Those responsible for implementing the NICE guidance need to address ophthalmologists' beliefs about the evidence of effectiveness for PDT and draw upon supportive local individuals or networks to enhance the credibility of the guidance.

KW - subfoveal choroidal neovascularization

KW - macular degeneration

KW - verteporfin

U2 - 10.1186/1472-6963-5-34

DO - 10.1186/1472-6963-5-34

M3 - Article

VL - 5

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

M1 - 34

ER -